Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Sangre
|
January 1, 1979
[Acquired granulocyte function impairments (author's transl)]
M Giralt, J Loza, I Egurbide
Sangre
|
January 1, 1979
[Spontaneous spleen rupture as presenting feature and cause of death in chronic myelogenous leukaemia (author's transl)]
J Loza, I Egurbide, G Ramírez, et al.
Sangre
|
February 1, 1992
[Hodgkin's disease. Our 9-year experience with the 1980 protocol]
J Marín, R Lasa, I Egurbide, et al.
Sangre
|
June 1, 1991
[Non-Hodgkin's lymphoma in childhood. Review of 33 cases]
J R Furundarena, D Martínez Busteros, E Navarro, et al.
Leukemia
|
January 22, 2011
In vivo expression of an aberrant MYB-GATA1 fusion induces leukemia in the presence of GATA1 reduced levels
E Belloni, D Shing, C Tapinassi, et al.
Haematologica
|
June 22, 2001
Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL
J J Ortega, J M Ribera, A Oriol, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Sangre
|
January 1, 1979
[Acquired granulocyte function impairments (author's transl)]
M Giralt, J Loza, I Egurbide
Sangre
|
January 1, 1979
[Spontaneous spleen rupture as presenting feature and cause of death in chronic myelogenous leukaemia (author's transl)]
J Loza, I Egurbide, G Ramírez, et al.
Sangre
|
February 1, 1992
[Hodgkin's disease. Our 9-year experience with the 1980 protocol]
J Marín, R Lasa, I Egurbide, et al.
Sangre
|
June 1, 1991
[Non-Hodgkin's lymphoma in childhood. Review of 33 cases]
J R Furundarena, D Martínez Busteros, E Navarro, et al.
Leukemia
|
January 22, 2011
In vivo expression of an aberrant MYB-GATA1 fusion induces leukemia in the presence of GATA1 reduced levels
E Belloni, D Shing, C Tapinassi, et al.
Haematologica
|
June 22, 2001
Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL
J J Ortega, J M Ribera, A Oriol, et al.
Page
of 1